Oncology Matrix

We are excited to introduce Oncology Matrix, our new platform dedicated to delivering a comprehensive range of oncology-focused resources and developments

[Oncology Matrix @oncologymatrix]

In this episode, Colleen reflects on how self-advocacy transformed her experience with multiple myeloma. Learn more: https://t.co/N0U1I4i4Wb

#multiplemyeloma #oncology

[Oncology Matrix @oncologymatrix]

Dr. Tawagi discusses the recent approval of durvalumab plus BCG induction and maintenance in patients with BCG-naïve, high-risk NMIBC, highlighting key outcomes from the POTOMAC trial. Learn more: https://t.co/bUeNm8hCmH

#oncology #bladdercancer

[Oncology Matrix @oncologymatrix]

Dr. Abrams explains overall survival (OS) data from the HIMALAYA trial, including updated 5-year OS data. Learn more: https://t.co/I11mbTSToP

#HIMALAYAtrial #cancerresearch #clinicaltrials

[Oncology Matrix @oncologymatrix]

Hear from Eric and Sally on his multiple myeloma journey, and from his oncologist, Dr. Castaneda Puglianini, on why CAR T therapy was the right choice after relapse. Learn more: https://t.co/NBfJNu5Uyo

#MultipleMyeloma #CART

[Oncology Matrix @oncologymatrix]

In this episode, Colleen shares how a routine physical led to her diagnosis of smoldering multiple myeloma. Learn more: https://t.co/IOM32yKOyF

#multiplemyeloma #clinicaltrials

[Oncology Matrix @oncologymatrix]

Hear from Samuel Klempner, MD, as he discusses the role of the MATTERHORN regimen in resectable GC/GEJC. Learn more: https://t.co/GHti1z3Kql

#Oncology #Gastrointestinal

[Oncology Matrix @oncologymatrix]

Dr. Galsky discusses unmet needs for patients with high-risk non-muscle invasive bladder cancer (NMIBC). Learn more: https://t.co/5sRwnk2BKY

#oncology #bladdercancer

[Oncology Matrix @oncologymatrix]

In this episode, multiple myeloma survivor Otis and his wife and care partner, Tracy, share how they kept loved ones informed without becoming overwhelmed, Otis’s experience with CAR T therapy, and the ways their relationship has grown. Learn more: https://t.co/pO8s2RsuM4

[Oncology Matrix @oncologymatrix]

Multiple myeloma survivor Otis and his wife and care partner, Tracy, share their journey from a delayed diagnosis to CAR T therapy and remission. Learn more: https://t.co/TmGAlyUmt7

#multiplemyeloma #CARTtherapy

[Oncology Matrix @oncologymatrix]

Incase you missed the live session of the Oncology Matrix Metastatic Breast Cancer Webinar our recording is now live! Don’t miss out on the latest clinical findings in metastatic breast cancer. Learn more: https://t.co/qX7Pw9WsYt

[Oncology Matrix @oncologymatrix]

Haley Ellis, MD: Updated Efficacy Data from the TOPAZ-1 Clinical Trial. Learn more: https://t.co/MYfvpoqHgx

[Oncology Matrix @oncologymatrix]

Incase you missed the live session of the Oncology Matrix Meta Static Breast Cancer Webinar our recording is now live! Don’t miss out on the latest clinical findings in metastatic breast cancer. Learn more: https://t.co/qX7Pw9WsYt

[Oncology Matrix @oncologymatrix]

One day left to register for the Oncology Matrix Metastatic Breast Cancer webinar! Secure your spot and register today: https://t.co/THnKYqryFD

[Oncology Matrix @oncologymatrix]

We are 3 days away from the Oncology Matrix MBC Webinar! Register today to stay up to date with the latest clinical findings in metastatic breast cancer. https://t.co/THnKYqryFD

[Oncology Matrix @oncologymatrix]

Hear from our experts at the Oncology Matrix GI Cancers Webinar to explore the latest clinical findings in gastrointestinal cancers. Register: https://t.co/U8bTmFSfhY

[Tanios Bekaii-Saab, MD @GIcancerDoc]

Join us at the Oncology Matrix GI Cancer Webinar as we review #cholagiocarcinoma treatment data, key subset analyses, standards of care, and post–first-line/post-IO options in GI cancers.
Register Today: https://t.co/Khwx3BHsIc
#Oncology #MedOnc #GICancer
@oncologymatrix

[Oncology Matrix @oncologymatrix]

Register today and secure your spot for the Oncology Matrix GI Cancer Webinar! https://t.co/U8bTmFSfhY

[Oncology Matrix @oncologymatrix]

Hear from our experts at the Oncology Matrix GI Cancers Webinar to explore the latest clinical findings in gastrointestinal cancers. Register: https://t.co/U8bTmFSfhY

[Oncology Matrix @oncologymatrix]

In this new episode of Expert Perspectives in Multiple Myeloma, Mary Steinbach, DNP, APRN, and Eliza Parkin, NP, discuss the importance of educating patients about the safety profile of multiple myeloma treatment and guide patients through adverse events. https://t.co/2HTHs1OaTH

[Oncology Matrix @oncologymatrix]

This post hoc analysis of CARTITUDE-1 by Jagannath et al described OS, five-year and longer progression-free outcomes, associated biomarkers, and safety at a median follow-up of 61.3 months. https://t.co/vl8h4JnAfg